The NAC SCRT has
determined that given the current state of knowledge and evidence,
only hematopoietic stem cell transplants for blood diseases and
limbal stem cell transplants for corneal diseases can be performed as
standard therapy outside of clinical trials in India. All other
forms of stem cell transplants, including those with blood or marrow
derived stem cells, cord blood stem cells, mesenchymal stem cells and any
embryonic stem cell derived tissue shoud only be used within an
appropriately reviewed and monitored clinical trial that has been
registered on the ICMR clinical registry (www.ctri.nic.in)
and in accordance with current national guidelines.
Circular
Download Format
Indian institutions working in
the area of Stem Cell Research and Therapy should send
the information pertaining to their Institutional Committee for Stem
Cell Research and Therapy (IC-SCRT) as per format to the
following address :
Member Secretary,
National Apex Committee for Stem
Cell Research and Therapy
ICMR Headquarters Office,
Ramlingaswamy Bhawan,
New Delhi-110029.
Home Page |